<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:13.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
a:link, span.MsoHyperlink
	{color:#0563C1;
	text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-AU link="#0563C1" vlink="#954F72" style='word-wrap:break-word'>

<div class=WordSection1>

<h1><span lang=EN-US>Von Willebrand Disease</span></h1>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>Disease:</span></h2>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=95 valign=top style='width:70.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Pathophysiology</span></p>
  </td>
  <td width=507 valign=top style='width:380.2pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Reduced binding of platelets to each other and
  to collagen</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Reduced protection of circulating factor 8</span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top style='width:70.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Presentation</span></p>
  </td>
  <td width=507 valign=top style='width:380.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Bleeding: surgery, epistaxis, gum, period</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Normal platelet, INR, aPTT</span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top style='width:70.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Differentials</span></p>
  </td>
  <td width=507 valign=top style='width:380.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>i.e. bleeding diathesis with normal platelet,
  INR, aPTT</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:36.85pt;text-indent:-14.15pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Haemophilia – joint and muscle bleeding</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:36.85pt;text-indent:-14.15pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Abnormal platelets – very rare</span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top style='width:70.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Subtypes</span></p>
  </td>
  <td width=507 valign=top style='width:380.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>1: less</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>2: dysfunctional</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:36.85pt;text-indent:-14.15pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>2A: LOF – many causes</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:36.85pt;text-indent:-14.15pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>2B: GOF - ↑binding to platelet</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:36.85pt;text-indent:-14.15pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>2M: LOF - ↓binding to platelet</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:36.85pt;text-indent:-14.15pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>2N: LOF - ↓binding to factor 8 (behaves like
  Haemophilia)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>3: none</span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top style='width:70.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Problems</span></p>
  </td>
  <td width=507 valign=top style='width:380.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>High risk of surgical bleeding</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>High risk of neuraxial complications</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Doesn’t show up on usual tests</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>Peri-op management:</span></h2>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=113 valign=top style='width:84.75pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Testing</span></p>
  </td>
  <td width=489 valign=top style='width:366.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><u><span
  lang=EN-US>Pre-op tests:</span></u></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>vWF antigen assay</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>vWF / factor 8 function assay</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>DDAVP challenge</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>BGHO: because blood group affects levels</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><u><span
  lang=EN-US>Targets:</span></u></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Obstetrics &gt;50% at delivery or neuraxial,
  &gt;25% otherwise</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Major surgery &gt;50%</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Minor surgery &gt;30%</span></p>
  </td>
 </tr>
 <tr>
  <td width=113 valign=top style='width:84.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Treatment</span></p>
  </td>
  <td width=489 valign=top style='width:366.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><u><span
  lang=EN-US>General:</span></u></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Transfer to tertiary centre unless low risk</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Address all the other aspect of blood
  management</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Avoid all anti-platelets (includes NSAIDs)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Avoid neuraxial procedures altogether</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><u><span
  lang=EN-US>Specific:</span></u></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Discuss with haematology; treatment is
  dependent on subtype</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>TXA peri-op 3-5 days</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Nothing vs desmo vs blood products</span></p>
  </td>
 </tr>
 <tr>
  <td width=113 valign=top style='width:84.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>vWF sources</span></p>
  </td>
  <td width=489 valign=top style='width:366.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>DDAVP (↑level 3-5x)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:36.85pt;text-indent:-14.15pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Dose 0.3mcg/kg</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:36.85pt;text-indent:-14.15pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Onset 30 mins</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:36.85pt;text-indent:-14.15pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Duration 6-8 hours</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:36.85pt;text-indent:-14.15pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Not useful for type 3</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:36.85pt;text-indent:-14.15pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Contraindicated in type 2B</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:36.85pt;text-indent:-14.15pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Tachyphylaxis after 4 doses</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Cryoprecipitate (small amount of vWF)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:23.05pt;text-indent:-14.2pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>vWF concentrates e.g. Biostate (large amount
  of vWF)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:36.85pt;text-indent:-14.15pt;line-height:normal'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Dose 60-80 units/kg</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US>Feedback welcome at </span><a
href="mailto:ketaminenightmares@gmail.com"><span lang=EN-US>ketaminenightmares@gmail.com</span></a></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

</div>

</body>

</html>
